Tegretol Mixtúra, dreifa 20 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

tegretol mixtúra, dreifa 20 mg/ml

novartis healthcare a/s - carbamazepinum inn - mixtúra, dreifa - 20 mg/ml

Tegretol Tafla 200 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

tegretol tafla 200 mg

novartis healthcare a/s - carbamazepinum inn - tafla - 200 mg

Orserdu Evrópusambandið - íslenska - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - brjóstakrabbamein - innkirtla meðferð - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Neofordex Evrópusambandið - íslenska - EMA (European Medicines Agency)

neofordex

theravia - dexametason - mergæxli - barksterar til almennrar notkunar - meðferð við mörgum mergæxli.

Depo-Medrol Stungulyf, dreifa 40 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

depo-medrol stungulyf, dreifa 40 mg/ml

pfizer aps - methylprednisolonum acetat - stungulyf, dreifa - 40 mg/ml

Solu-Cortef Stungulyfsstofn og leysir, lausn 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

solu-cortef stungulyfsstofn og leysir, lausn 100 mg

pfizer aps - hydrocortisonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 100 mg

Solu-Cortef Stungulyfsstofn og leysir, lausn 250 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

solu-cortef stungulyfsstofn og leysir, lausn 250 mg

pfizer aps - hydrocortisonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 250 mg

Solu-Medrol Stungulyfsstofn og leysir, lausn 40 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

solu-medrol stungulyfsstofn og leysir, lausn 40 mg

pfizer aps - methylprednisolonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 40 mg